90 CEO MONTHLY / CEO 100 1 ISSUE 8 2019 , The healthcare and pharmaceuticals industries have tomove quickly to constantly adapt to an environment that has become defined by innovation and evolution. In this ever-changing landscape, RedefineCompliance look to be a tonic, with a goal tomake compliance simple. Following Dan Sherry, RedefineCompliance’s CEO, being recognised as the 2019 CEO of the Year for the United Kingdom, we endeavoured to find out more about the company’s ethos, culture and future. Making Compliance Simple “In order for compliance to be effective it must be simple, that is fundamental.” - Dan Sherry, CEO of RedefineCompliance Ltd. The healthcare and pharmaceutical industries are two of the fastest changing industries on the global business landscape. Driven by technological innovation, the sector’s goliaths have created a large-scale ‘arms race’, as each – in their efforts to corner a new product or segment – become eager to capitalise on the benefits of being first to market. The role of regulation is to keep pace with the fastest of these conglomerates to ensure the safe and efficacious use of medicines and medical technology. As such, regulation can be perceived as complicated, complex and convoluted, difficult for many companies to understand and to monitor. Compliance has become a matter of expertise, and when it comes to expertise, we believe that few can match RedefineCompliance’s positive and effective approach to these challenges. As Dan explains, RedefineCompliance was created from the ground up to make regulatory compliance simple and easy to digest, reducing the complexity for companies and their employees. “We are experts in building effective compliance programmes in the Pharmaceutical industry. We make compliance simple for the organisations that we work with, through the design and implementation of governance structures, process architecture, management systems and training solutions. As members of BSI, and through the utilisation of tools such as ISO quality management architecture, we provide effective & strategic advice and guidance on compliance and regulatory management; ethical interactions in healthcare, however, remain a focus for the company.” “We want compliance to be simple and jargon free. Moreover, we always aim to embed our ways of working within the organisations that we work with, so that they build their own internal capabilities and are able to continuously improve their compliance programs long after we have finished our work.” By approaching compliance from this new, innovative and positive perspective, RedefineCompliance might be considered disruptors in an industry which can be perceived, on the whole, slow to evolve in order to meet the ethical, regulatory and technological challenges that exist today. Instead, with RedefineCompliance’s commitment to simplicity, they act as silencers to the problems that plague good compliance, ensuring accessibility and seamlessness where complexity normally reigns supreme. Though they focus primarily on the healthcare and pharmaceutical sectors, RedefineCompliance’s expertise extends beyond both to cover a plethora of sub-sectors and areas. “As briefly touched on, the company specialises in ethical interactions within the healthcare community, with a primary focus on ethical promotional interactions, materials and activities, with a fundamental component to embedding good compliance being training. Finally, we are working towards being able to provide guidance at a more generic corporate level, covering all aspects of privacy, confidentiality, contracts and agreements in the future. Dan continues, adding more insight into the company’s methodology. “Good compliance requires a holistic approach and so we have acquired the tools to create comprehensive compliance programs that Mar19250 MAR19250
RkJQdWJsaXNoZXIy NTY1MjM3